Sign In

Anjan Chatterji

Creating value in the biopharma, med-tech, & diagnostic worlds through the experience that counts & proprietary strategies in corp. finance, M&A, equity capital markets, debt arbitrage, & regulatory/IP.

Anjan K. Chatterji, MBA, J.D., LL.M. is a senior-level executive with extensive experience in the biopharmaceutical, medical device/tech, and related industries.1 He is the Managing Member of Horatio Washington Ventures LLC, a position he has held since June 2014.1 In this role, he focuses on public and private investments and advisory in pharmaceutical, biologics, and MedTech companies, as well as scientific innovation and IP funding.1

Chatterji's professional background includes:

  1. Partner at Wilson Chatterji Ventures (October 2023 - Present), focusing on rare disease and oncology investments.1
  2. General Partner at OccVenBio (November 2022 - Present), involved in impact investment and advisory in healthcare and business growth.1
  3. Advisory Board Member for several companies, including Windgap Medical, Inc. and Oxeia Biopharmaceuticals, Inc.1
  4. Former President and CFO of BioActivDx LLC (February 2020 - November 2023), a med-tech device company developing PCR-based breakthroughs.1
  5. Co-founder of Vital Medicine, LLC (January 2010 - November 2023), focusing on innovative therapies for joint and arthritic pain.1

Chatterji has also held positions at prominent firms such as Foley & Lardner LLP, Deloitte Consulting, and PwC, where he gained experience in healthcare economics, life sciences business valuations, and economic dispute services.1

His educational background includes an MBA, J.D., and LL.M., although the specific institutions are not mentioned in the provided search results.1

Chatterji's LinkedIn profile (username: achatt) showcases his expertise in the intersection of healthcare, technology, and law/finance through his experience in founding, operating, and investing in pharmaceutical and medical technology companies.234

Highlights

Aug 17 · linkedin

Embrace your differences. Monetize it. There’s a reason you don’t fit in with the flock of sheep (and it’s good, just takes time). #power

Aug 14 · linkedin

2 years go today…. I was found unresponsive from a TBI. However, little did I know that the battle didn’t end post-admissions. I went though a year of challenge and still recovering from conventional ventilation side effects. ICU needs tech disrupters like VENTSAFE. The technology used in ICU is decades old…. No real advancements, just archaic tubes, vents, and over sedation.

We can’t ignore this issue. It’s innovators like Sean Kirby Degmetich that can help change.

Let’s solve this invisible pandemic… post ICU effects. It’s a double edged sword. I recovered from the TBI faster than the side effects of convential ventilation - how is this possible?

#VAP #VILI #ICUDelirium #ARDS #patientadvocacy #controlandagency #dayonenotoneday

Related Questions

What are some of the key projects Anjan Chatterji has worked on at Horatio Washington Ventures?
How did Anjan Chatterji's experience with concussions influence his career in biotech?
What is the focus of Horatio Washington Ventures in the biopharmaceutical industry?
Can you provide more details about Anjan Chatterji's role at Oxeia Biopharmaceuticals?
What are the main investment areas for OccVenBio, where Anjan Chatterji is a General Partner?
Anjan Chatterji
Anjan Chatterji, photo 1
Anjan Chatterji, photo 2
Add to my network

Location

New York, New York